Control Bionics (ASX:CBL) share price doubles after successful IPO

The Control Bionics Limited (ASX:CBL) share price is rocketing higher after completing its IPO this morning…

A medical researcher works on a bichip, indicating share price movement in ASX tech companies

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Control Bionics Limited (ASX: CBL) share price landed on the ASX boards this morning following the successful completion of its initial public offering (IPO). And what a start it has had!

At the time of writing, the medical technology company's shares are fetching $1.21.

This is more than double the Control Bionics listing price of 60 cents.

What is Control Bionics?

Control Bionics is a medical technology company founded by former CNN anchor, Peter Ford.

Whilst working at CNN, Mr Ford taught himself to code and, inspired by Stephen Hawking, began developing software that would allow severely disabled people to operate and communicate using only their thoughts and neural signals.

The company notes that this technology is making a huge difference to the lives of those using it.

Furthermore, it has now gone well beyond basic communication and can allow those with diseases such as motor neurone disease (MND) to do things that haven't been possible for a long time. This includes gaming, controlling a television, and continuing with careers.

An example of the latter is Professor Justin Yerbury, who was recognised in this year's Australia Day honours list for his outstanding contribution to research regarding MND.

Using Control Bionic's NeuroNode system, Mr Yerbury has been able to continue teaching and researching in his field of Neurodegenerative Diseases at Wollongong University.

In FY 2020, the company generated $3.1 million in product revenue, which represented growth of 297% on FY 2019. And despite challenges presented by COVID-19, it has achieved unaudited revenue growth of approximately 41% in the first quarter compared to the prior corresponding period.

The Control Bionics IPO.

Control Bionics' IPO raised a total of $15 million at $0.60 per new share. This gave the company a $50 million market cap.

Management revealed that demand was so strong for its IPO that it was restricted to priority offer applications only after just a week.

Speaking about the offering, Chairman Roger Hawke commented: "The funds raised by this Offer will provide Control Bionics with working capital to execute our growth strategy in North America, increase our presence in Australia and prepare for entry to other priority markets including Japan. Additionally, funds will be used to support the marketing for existing products and to fund continued development of the hardware and software for a range of new, advanced applications."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of CBL Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Man sitting in a plane seat works on his laptop.
Opinions

Expert reveals 2 ASX stocks to sell — and 1 is a recent IPO

Toby Grimm from Baker Young shares his insights.

Read more »

Happy teen friends jumping in front of a wall.
Share Gainers

Guess which 4 ASX 200 shares are rocking new 52-week highs today!

Investors just sent these four ASX 200 shares to one-year-plus highs.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Broker Notes

Why are Platinum shares rocketing 13% today?

This fund manager is getting a lot of love from investors today. Let's find out why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Evolution Mining, Orthocell, Platinum, and Turaco shares are charging higher

These shares are having a better day that most on Thursday.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why CSL, Imricor, Jumbo, and Netwealth shares are falling today

These shares are under pressure on Thursday. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Broker Notes

Morgans says these ASX stocks can rise 30% to ~50%

Let's see which shares could generate big returns for investors.

Read more »

a mine worker holds his phone in one hand and a tablet in the other as he stands in front of heavy machinery at a mine site.
Broker Notes

Does Macquarie rate Fortescue shares a buy, hold or sell?

The broker has given its verdict on this popular mining stock.

Read more »

group of traders cheering at stock market
Share Market News

We could see the ASX 200 at 9,000 points by 2026. Here's why.

I wouldn't be shocked to see more records this year...

Read more »